Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PECS-112
- Development stage
- Preclinical
- Lead developer
- Phytecs
- Modality
- Small Molecules
01
Overview
PECS-112 is a preclinical-stage small molecule fluorinated cannabidiol (F-CBD) derivative developed by Phytecs Pharm. It is designed to modulate the endocannabinoid system (ECS) and has demonstrated significantly greater potency than natural cannabidiol (CBD) in preclinical models. The compound is being investigated for a broad range of therapeutic applications, including neuropsychiatric disorders such as anxiety, psychosis, schizophrenia, and obsessive-compulsive disorder (OCD), as well as epilepsy, chronic pain, and various inflammatory skin conditions like dermatitis, psoriasis, atopic eczema, and acne. Phytecs Pharm collaborates with several academic and research institutions, including the University of São Paulo and the European Brain Research Institute, to advance its ECS-focused pipeline.
- Other names
- fluorinated cannabidiol derivativeF-CBD derivative
Beyond the preview
Go deeper on PECS-112.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PECS-112.